Biktarvy, formally known as bictegravir, is a potent single-tablet regimen for treating HIV infection. This formula unites three crucial antiviral drugs: bictegravir, emtricitabine, and tenofovir alafenamide. It operates by preventing the the viral ability to replicate within the body, significantly lowering the viral load. For many individuals,